FPW
DGX icon

Fairvoy Private Wealth’s Quest Diagnostics DGX Stock Holding History

Fairvoy Private Wealth’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Sell
2,189
-455
-17% -$89.3K 0.09% 142
2026
Q1 		$518K Sell
2,644
-118
-4% -$22.9K 0.12% 140
2025
Q4 		$479K Buy
2,762
+718
+35% +$131K 0.11% 120
2025
Q3 		$390K Buy
+2,044
New +$363K 0.09% 140

Other funds holding DGX

EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

Fairvoy Private Wealth's DGX Position: Q2 2026 in Review

Fairvoy Private Wealth reduced its Quest Diagnostics (DGX) stake by 17% in Q2 2026, selling an estimated $89.3K and leaving 2,189 shares worth $464K. The position accounts for 0.09% of the portfolio, ranked #142.

Fairvoy Private Wealth first reported a position in DGX in Q3 2025 and has held it in 4 quarters since. The position peaked at $518K in Q1 2026. 210 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Fairvoy Private Wealth held 2,189 shares of Quest Diagnostics worth $464K as of Q2 2026.
  • Fairvoy Private Wealth sold 455 Quest Diagnostics shares in Q2 2026, an estimated $89.3K.
  • Quest Diagnostics made up 0.09% of Fairvoy Private Wealth's portfolio in Q2 2026, its #142 holding.
  • Fairvoy Private Wealth first reported a position in Quest Diagnostics in Q3 2025 and has held it in 4 quarters since.
  • Fairvoy Private Wealth's Quest Diagnostics position peaked at $518K in Q1 2026.
  • 210 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Fairvoy Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.